Neko Health raised $700M while Rime secured $24M for its voice AI platform in healthcare. These fundraising rounds highlight investor appetite for technology that streamlines clinical workflows and diagnostic processes.
Summaries like this, in your inbox every morning.
Sign up free →What happened
Neko Health raised $700M in funding. Separately, Rime secured $24M for its voice AI platform designed for healthcare.
Why it matters
These deals reflect ongoing investment in healthcare technology, including diagnostic imaging (Neko Health) and AI-powered clinical documentation tools (Rime's voice platform), suggesting investor confidence in automation and efficiency gains in healthcare workflows.
What to watch
Both companies are now better capitalized to expand their services; Neko Health's $700M positions it as a major player in health diagnostics, while Rime's $24M supports development of its voice AI for clinical use.
Neko Health and Rime have both secured significant funding in 2026, according to the Fierce Healthcare Fundraising Tracker. Neko Health raised $700M, establishing itself as a well-capitalized healthcare technology company. In a separate transaction, Rime secured $24M in funding for its voice AI platform tailored to the healthcare industry. The voice AI platform is positioned as a tool for healthcare applications, though the article does not detail its specific clinical use cases. These fundraising events are part of a broader trend of capital flowing into healthcare technology ventures during 2026.
The two fundraising announcements in this report underscore the healthcare sector's openness to venture capital investment in 2026. Neko Health's $700M raise represents a substantial capital influx, signaling investor confidence in its business model. Rime's $24M funding, while smaller in absolute terms, reflects the market's sustained interest in voice AI technology applied to healthcare settings—a space where automation of clinical documentation and related workflows has become a priority. Together, these rounds suggest that investors view technology addressing diagnostic efficiency and clinical administration as high-potential areas.
No comments yet. Be the first to share your thoughts!
Log in to join the discussion
Get curated AI news from 200+ sources delivered daily to your inbox. Free to use.
Get Started FreeFree · takes 30 seconds · unsubscribe anytime
1 minute a day. The AI essentials.
200+ sources · Email / LINE / Slack
